(American Friends of Tel Aviv University) In a new study published in Nature Neuroscience, Dr. Inna Slutsky of Tel Aviv University’s Sackler Faculty of Medicine finds that the amyloid-beta protein, currently the target of Alzheimer’s drug research, is essential for normal information transfer through nerve cell networks in the brain. “If this protein is removed from the brain,” says Dr. Slutsky, “it may cause an impairment of neuronal function, as well as a further and faster accumulation of amyloid-beta in Alzheimer’s.” [...]
|
|||||
|
Fatal error: Cannot redeclare searchengine() (previously declared in /home2/sciencg6/public_html/reactivereports/chemistry-blog/wp-content/themes/atahualpa353/functions.php(532) : eval()'d code:19) in /home2/sciencg6/public_html/reactivereports/chemistry-blog/wp-content/themes/atahualpa353/functions.php(532) : eval()'d code on line 25 | |||||